The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Cardiome Pharma Corp Hits New 100-day High

Cardiome Pharma Corp closed up Friday by $0.01 or 0.22% to $4.63 and setting a new 100-day high. Over the last five days, shares have gained 8.69% and 23.47% year to date. Shares have underperformed the S&P TSX by 31.58% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.08
Updated April 28 3:21 PM EDT. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.51%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Total other revenue--------
Total revenue7567
Gross profit5446
Total cost of revenue2121
Total operating expense129128
Selling / general / administrative9786
Research & development0000
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)001--
Other operating expenses, total--------
Operating income-5-4-6-1
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Income before tax-6-5-7-1
Income after tax-6-5-8-1
Income tax, total0000
Net income-6-5-8-1
Total adjustments to net income--------
Net income before extra. items-6-5-8-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-5-8-1
Inc. avail. to common incl. extra. items-6-5-8-1
Diluted net income-6-5-8-1
Dilution adjustment--------
Diluted weighted average shares32282020
Diluted EPS excluding extraordinary itemsvalue per share-0.18-0.19-0.37-0.06
Dividends per sharevalue per share--
Diluted normalized EPSvalue per share-0.18-0.19-0.32-0.06